デフォルト表紙
市場調査レポート
商品コード
1319974

女性の健康治療薬市場:タイプ別、流通チャネル別-2023-2030年の世界予測

Women's Health Therapeutics Market by Type, Distribution Channel - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.56円
女性の健康治療薬市場:タイプ別、流通チャネル別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

女性の健康治療薬の世界市場は、2023年に654億9,000万米ドル、CAGR 10.67%で大幅な成長が予測され、2030年には1,338億2,000万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の女性の健康治療薬市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.女性の健康治療薬の世界市場規模および予測は?

2.予測期間中、世界の女性の健康治療薬市場を形成するCOVID-19の阻害要因と影響は?

3.女性の健康治療薬の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.女性の健康治療薬の世界市場における競争戦略は?

5.女性の健康治療薬の世界市場における技術動向と規制の枠組みは?

6.女性の健康治療薬の世界市場における主要ベンダーの市場シェアは?

7.女性の健康治療薬の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 女性の間で慢性的な健康状態の発生率が増加
      • 女性の健康と性的健康を改善するための政府の取り組み
      • 不妊治療や更年期障害の治療が増加
    • 抑制要因
      • 健康保険がないため高額な治療費がかかる
    • 機会
      • デジタルでパーソナライズされたヘルスケアとフェムテックの台頭
      • 十分な治療が受けられていない女性特有の症状を治療するための細胞療法と遺伝子療法の進歩
    • 課題
      • さまざまな治療法の副作用に関する懸念
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 女性の健康治療薬市場:タイプ別

  • 感染
  • 腫瘍学
    • 子宮頸がん
    • 卵巣がん
    • 子宮がん
  • 妊娠
  • 膣がんおよび外陰がん

第7章 女性の健康治療薬市場:流通チャネル別

  • ドラッグストアおよび小売薬局
  • 病院薬局
  • オンライン薬局

第8章 南北アメリカの女性の健康治療薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の女性の健康治療薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの女性の健康治療薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第12章 掲載企業一覧

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. WOMEN'S HEALTH THERAPEUTICS MARKET RESEARCH PROCESS
  • FIGURE 2. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 5. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 6. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. WOMEN'S HEALTH THERAPEUTICS MARKET DYNAMICS
  • FIGURE 8. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. WOMEN'S HEALTH THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. WOMEN'S HEALTH THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. WOMEN'S HEALTH THERAPEUTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 5. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY INFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 7. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY OVARIAN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY UTERINE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY PREGNANCY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY VAGINAL & VULVAR CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 14. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DRUG STORES & RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM WOMEN'S HEALTH THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. WOMEN'S HEALTH THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. WOMEN'S HEALTH THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. WOMEN'S HEALTH THERAPEUTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-957C47F94732

The Global Women's Health Therapeutics Market is forecasted to grow significantly, with a projected USD 65.49 billion in 2023 at a CAGR of 10.67% and expected to reach a staggering USD 133.82 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Women's Health Therapeutics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Women's Health Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Infection, Oncology, Pregnancy, and Vaginal & Vulvar Cancer. The Oncology is further studied across Cervical Cancer, Ovarian Cancer, and Uterine Cancer. The Vaginal & Vulvar Cancer is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. The Drug Stores & Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Women's Health Therapeutics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Women's Health Therapeutics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Women's Health Therapeutics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Women's Health Therapeutics Market?

4. What is the competitive strategic window for opportunities in the Global Women's Health Therapeutics Market?

5. What are the technology trends and regulatory frameworks in the Global Women's Health Therapeutics Market?

6. What is the market share of the leading vendors in the Global Women's Health Therapeutics Market?

7. What modes and strategic moves are considered suitable for entering the Global Women's Health Therapeutics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Women's Health Therapeutics Market, by Type, 2022 vs 2030
  • 4.3. Women's Health Therapeutics Market, by Distribution Channel, 2022 vs 2030
  • 4.4. Women's Health Therapeutics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidence of chronic health conditions among women
      • 5.1.1.2. Government initiatives to improve women's health and sexual wellness
      • 5.1.1.3. Increasing prevalence of infertility and menopausal treatments
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment due to lack of health insurance
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in digital personalized healthcare and femtech
      • 5.1.3.2. Advances in cell and gene therapy to treat underserved female-specific conditions
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to side-effects of various therapies
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Women's Health Therapeutics Market, by Type

  • 6.1. Introduction
  • 6.2. Infection
  • 6.3. Oncology
    • 6.3.1. Cervical Cancer
    • 6.3.2. Ovarian Cancer
    • 6.3.3. Uterine Cancer
  • 6.4. Pregnancy
  • 6.5. Vaginal & Vulvar Cancer

7. Women's Health Therapeutics Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Drug Stores & Retail Pharmacies
  • 7.3. Hospital Pharmacies
  • 7.4. Online Pharmacies

8. Americas Women's Health Therapeutics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Women's Health Therapeutics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Women's Health Therapeutics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing